All In MedTech

FDA Clearance Tracker · P940035-S006

NMP22 BLADDERCHEK TEST KIT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 15, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 15, 2011

Approved

Time to decision

188 days

Received May 11, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P940035-S006
Device name
NMP22 BLADDERCHEK TEST KIT
Applicant location
Scarborough, ME
Received
May 11, 2011
Decided
Nov 15, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P940035

Device type

Device class
Class III

Every decision under product code NAH

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MANUFACTURING SITE LOCATED AT ALERE SCARBOROUGH, INC. IN SCARBOROUGH, MAINE.

Source documents

Other decisions for Abbott Diagnostics Scarborough, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

6 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.